HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

10th Edition of World Nanotechnology Conference

March 10-12, 2025

March 10 -12, 2025 | Rome, Italy
World Nano 2022

Subas Chandra Dinda

Subas Chandra Dinda, Speaker at Nanoscience conferences
The Neotia University, India
Title : Nanotheranostics in drug targeting


Nanotheranostics is the integration of diagnostic and therapeutic function in one system at nono-size level, which attracts attention in personalized medicine. Because treating cancer is not a one-size-fits-all scenario, it requires therapy to be adapted to the patient's specific biomolecules. It identifies biomarkers to gain an understanding of the diagnosis and in turn treating the specific disorder based on the precise diagnosis. By predominantly utilizing the unique properties of nanoparticles to achieve biomarker identification and drug delivery, nanotheranostics can be applied to noninvasively discover and target image biomarkers and further deliver treatment based on the biomarker distribution. Different drug delivery systems such as liposomes, microspheres, nanoparticles, nonogels and nonobiocapsules have been used to improve the bioavailability of the drug in the brain, but microchips and biodegradable polymeric nanoparticulate careers are found to be more effective therapeutically in treating brain tumor. The physiological approaches also utilized to improve the transcytosis capacity of specific receptors expressed across the BBB. It is found that the low-density lipoproteins related protein (LPR) with engineered peptide compound (EpiC) formed the platform incorporating the Angiopep peptide as new effective therapeutics.  The lipid-based formulations comprise nanoemulsions, solid-lipid nanoparticles (SLNs), nano-structured lipid carriers (NLCs), liposomes, and niosomal systems, etc. have found more promising antitubercular activity as its intended for targeted drug delivery especially to the infected part. Further mannosylation of liposomes offers tremendous results in TB chemotherapy as it directly binds to mannose receptors available on the surface of alveolar macrophages resulting mycobacterium destruction. SLNs and manosylated SLNs are the advanced form of the lipid formulations, which found to enhance the drug uptake at the infected organ and show significant in vivo anti-tubercular activity with reduced toxicity.

Recently it has been found that the use of nanotechnology in the field of pharmaceutical biotechnology helps in improving the drug delivery strategy including the kinetics and therapeutic index to solve the delivery problems of some biotech drugs including the recombinant proteins and oligonucleotides. Use of nanotechnological based formulations and nanomaterials are increasing day-by-day in wide range covering a broad typology of applications, from design and development of targeted drug delivery systems, manufacturing of pesticides, domestic appliances, textiles, to bioremediation engineering. There are therefore concerns about the environmental risks or bioaccumulation related issues that may arise particularly resulting from the application of drug loaded nano-carriers or effect of pesticides that reach the natural ecosystems.


Dr. Subas Chandra Dinda, who is serving at present as Professor & Head, Department of pharmaceutics, Teerthanker Mahaveer University, India is found to be having a wide research experience in the frontier of Drug Delivery and Drug Targeting Research covering the area of design and development of Matrix systems, Floating Drug delivery systems, Muco-adhesive microcapsules, and Nano-particle based formulations. He explored several poorly bio-available drugs through muco-adhesive as well as nano-particle based dosage forms and found to be very effective through oral route.

He also actively involved in guiding the scholars in the field of Drug Delivery System as well as interdisciplinary research covering the area of Drug Synthesis and Herbal Drug Research under the joint collaboration with the teachers from other University as well. To date some of his research finding claimed patents and published in more than hundreds of peer reviewed journals for the benefit of scientific community.

He serves as reviewer of many journals including ELSEVIER, SPRINGER, and SCIENCE DIRECT publications. To his credit he supervised/awarded more than 18 Ph.D candidates in the field of pharmaceutical sciences for the professional development and having a vast administrative experience in establishing the new pharmacy institutions as well as designed new pharmacy course curricula as the chairperson of Board of Studies/Council for the development of pharmaceutical sciences at Berhampur University in India as well as Mekelle University in Ethiopia.